Major Growth Driver Identified in 2025 Pharmacogenetic Testing Market: Impact Of Personalized Medicine On The Growth Of The Pharmacogenetic Testing Market

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Pharmacogenetic Testing Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size of pharmacogenetic testing has seen brisk growth in recent times and is anticipated to surge from $12.37 billion in 2024 to $14.35 billion in 2025, representing a compound annual growth rate (CAGR) of 16.1%. Factors contributing to this growth during the historical period include the enhancement of overall drug effectiveness, the rising usage of personalized medicine, the growing necessity for precise diagnosis, a heightened focus on pharmacogenetic testing, and escalating healthcare costs.

Pharmacogenetic Testing Market Size Forecast: What's the Projected Valuation by 2029?
Predictions suggest a swift expansion in the market size for pharmacogenetic testing in the coming years. The market is projected to reach $25.77 billion by 2029, growing at a compound annual growth rate (CAGR) of 15.8%. This predicted growth during the forecast period can be traced back to burgeoning R&D in biotechnology and healthcare, augmenting healthcare costs, a surge in chronic illness cases, improved accessibility, and the advent of telemedicine and digital health. Major developments anticipated during this period include advancements in pharmacogenetic testing, genomic technologies, technological innovations, progression in companion diagnostics, and revolutionary diagnostic tests.

View the full report here:
https://www.thebusinessresearchcompany.com/report/pharmacogenetic-testing-global-market-report

What Are the Drivers Transforming the Pharmacogenetic Testing Market?
The growth of the pharmacogenetic testing market is projected to be driven by escalating demand for personalized medicine. Personalized or precision medicine is a healthcare approach engineered around the unique characteristics of an individual patient in order to make apt healthcare decisions and treatments. The upswing in personalized medicine is attributed to factors such as superior treatment results, emphasis on prevention and early diagnosis, and its cost-effective nature. Pharmacogenetic testing, a key part of personalized medicine, studies an individual's genetic composition to determine responses to certain drugs. This empowers healthcare professionals to adapt treatments as per genetic indicators, thereby maximizing drug effectiveness and limiting undesired reactions. For example, the Personalized Medicine Coalition, an American non-profit organization, revealed that in February 2024, the FDA sanctioned 16 new personalized therapies aimed at patients suffering from rare ailments in 2023, more than double the number approved in 2022. Hence, the upsurge in demand for personalized medicine is fuelling the progression of the pharmacogenetic testing market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19139&type=smp

What Long-Term Trends Will Define the Future of the Pharmacogenetic Testing Market?
Significant enterprises in the pharmacogenetics testing market are innovating advanced pharmacogenomics testing services like prescription-based pharmacogenetic testing to establish their position in the industry. The concept of prescription-based pharmacogenetic testing entails genetic examinations specifically requested or arranged by healthcare practitioners to examine a patient's genetic structure before prescribing medicines. For example, in May 2023, UCSF, a healthcare enterprise based in the US, introduced its own pharmacogenomics testing service. This is geared towards enhancing the precision of medical procedures. This pharmacogenomics testing service by UCSF enables healthcare providers to personalize drug treatments to align with a person's genetic profile. This aims not only to improve drug effectiveness but also to lessen adverse effects and to bolster strategies for personalized medicine.

Which Segments in the Pharmacogenetic Testing Market Offer the Most Profit Potential?
The pharmacogenetic testingmarket covered in this report is segmented -

1) By Type: Whole Genome Sequencing, Whole Exome Sequencing, Array-Based Tests, Single Gene Tests
2) By Drug Type: Prescription Drugs, Nutraceuticals, Recreational Drugs, Herbal Supplements, Vitamins, Over-The-Counter Medications
3) By Therapeutic Area: Cardiology, Gastroenterology, Anesthesiology, Genomics, Endocrinology, Immunology And Hypersensitivity, Dermatology, Gynecology, Oncology, Other Therapeutic Areas
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacies, Mail-Order Pharmacies, Direct-to-Customer Services
5) By End User: Healthcare Providers, Pharmaceutical And Biotechnology Companies, Centers And Academic Institutes, Other End Users

Subsegments:
1) By Whole Genome Sequencing: Illumina Sequencing, Ion Torrent Sequencing, Pacific Biosciences Sequencing, Oxford Nanopore Sequencing
2) By Whole Exome Sequencing: Capture-Based Exome Sequencing, Targeted Enrichment Exome Sequencing, Hybridization-Based Exome Sequencing
3) By Array-Based Tests: SNP Array Testing, Expression Array Testing, Copy Number Variation Array Testing
4) By Single Gene Tests: Targeted Gene Panels, Mutation Detection Tests, Sequencing Of Specific Genes

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=19139&type=smp

Which Firms Dominate the Pharmacogenetic Testing Market by Market Share and Revenue in 2025?
Major companies operating in the pharmacogenetic testing market are CVS Health Corporation, Thermo Fisher Scientific Inc., Quest Diagnostics Incorporated, Eurofins Scientific Inc., Bio-Rad Laboratories, Precision Medicine Advsiors, Azenta Life Sciences, Fulgent Genetics, Pacific Biosciences of California Inc., Castle Biosciences, 23andMe Holding Co., Helix Inc., Genomind Inc., MD Labs, Sonic Genetics, AutoGenomics Inc., LabClinics SA, Gene By Gene Ltd., Xcode Life Sciences, YouScript, RxGenomix LLC

Which Regions Offer the Highest Growth Potential in the Pharmacogenetic Testing Market?
Asia-Pacific was the largest region in the pharmacogenetic testing market in 2024 and it is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmacogenetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19139

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.